In recent years, I have focused my professional efforts and talents on unlocking value in firms located in the Iberian Peninsula, helping them achieve their full potential and provide significant returns to their investors.
I am currently partner of Eneas Alternative Investments, a private equity firm that invests in disruptive, tech-enabled companies and in some ready-to-grow local champions. There, I oversee the development of the firm’s international activities and its efforts to strengthen the companies we invest in.
I am also president of one of our portfolio companies, Lug Healthcare Technology, a Spanish technology company that specialized in the development of traceability, safety, efficiency and quality solutions for critical processes that take place in hospital pharmacies and research labs.
According to research by John Hopkins University, medical errors are the third leading cause of death in the U.S., after heart disease and cancer. The study concludes that more than 250,000 people die every year due to medical mix-ups. At Lug Healthcare Technology, our goal is to address this issue by reducing the number of errors in the administration of prescribed medication.
My partners at Eneas Alternative Investments and I are committed to identifying and cultivating other businesses, allowing them to fulfill their respective missions. We are convinced that there are many more success stories to come.